A study from Japan showed that neoadjuvant chemoradiotherapy on rectal cancer increased the CD8 + tumor infiltrating lymphocytes compared to patients not given chemoradiotherapy [47], suggesting that anti-tumor immunity was enhanced by chemoradiotherapy. Here, CD8A is linked to neoplasm.